Skip to main content
SpringerLink
Log in

Presepsin:albumin ratio and C-reactive protein:albumin ratio as novel sepsis-based prognostic scores

A retrospective study

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Objective

To investigate the prognostic value of the presepsin:albumin ratio and C‑reactive protein:albumin ratio in patients with sepsis in the intensive care unit (ICU).

Methods

A total of 228 (129 males and 99 females) patients with newly diagnosed sepsis were included in the study. The relationship between the C‑reactive protein:albumin ratio, presepsin:albumin ratio, clinicopathologic parameters, and overall survival were investigated. The associations between C‑reactive protein:albumin ratio and presepsin:albumin ratio were evaluated alongside other inflammation-based prognostic scores such as quick Sepsis Related Organ Failure Assessment (qSOFA).

Results

The presepsin:albumin ratio was significantly higher in non-survivors (p < 0.01). Patients with a high presepsin:albumin ratio had worse overall survival compared with patients with high C‑reactive protein:albumin ratio levels (p < 0.001).

Conclusion

Presepsin and presepsin:albumin ratio are markers of adverse prognosis in patients with sepsis and are superior to C‑reactive protein and C‑reactive protein:albumin ratio for this purpose. Presepsin:albumin ratio may be a novel marker of poor prognosis in patients with sepsis in intensive care units.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ali TF, Ali AMA, Elnakeeb MM, Bendary NMH. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis. Clin Chim Acta. 2016;460:93–101.

    Article  CAS  Google Scholar 

  2. Protti A, Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care. 2006;10:228.

    Article  Google Scholar 

  3. Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit Care. 2013;17:R244.

    Article  Google Scholar 

  4. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med. 2003;9:517–24.

    Article  CAS  Google Scholar 

  5. Groselj-Grenc M, Ihan A, Pavenik-Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C‑reactive protein in sepsis of critically ill neonates and children. Intensive Care Med. 2009;35(11):1950–8.

    Article  CAS  Google Scholar 

  6. Herzum I, Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem. 2008;15(6):581–7.

    Article  CAS  Google Scholar 

  7. Reinhart K, Meisner M, Brinkhorst FM. Markers for sepsis diagnosis: what is useful? Crit Care Clin. 2006;22(3):503–19.

    Article  CAS  Google Scholar 

  8. Endo S, Aikawa N, Fujishima S, et al. Usefulness of procalcitonin serum level fort he discrimination of severe sepsis: a multicenter prospective study. J Infect Chemother. 2006;14(3):244–9.

    Article  CAS  Google Scholar 

  9. Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of a modified early warning system for acute medical admission and comparision with C‑reactive protein/albumin ratio as a predictor of patient outcome. Clin Med. 2009;9:30–3.

    Article  Google Scholar 

  10. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD 14 is an acute-phase protein. J Immunol. 2004;172(7):4470–9.

    Article  CAS  Google Scholar 

  11. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:762–74.

    Article  CAS  Google Scholar 

  12. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.

    Article  Google Scholar 

  13. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States analysis of incidence, outcome and associated costs of care. Crit Care Med. 2001;29:1303–10.

    Article  CAS  Google Scholar 

  14. Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med. 2011;24:12–4.

    Article  CAS  Google Scholar 

  15. Naitoh K, Shirakawa K, Hirose J, et al. The new sepsis marker sCD14-ST (PRESEPSİN): introduction mechanism in the rabbit sepsis mpdels. Crit Care. 2010;14:P19.

    Google Scholar 

  16. Rivers EP, Ahrens T. Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation. Crit Care Clin. 2008;24(3):S1–S47.

    Article  CAS  Google Scholar 

  17. Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter pospective study. J Infect Chemother. 2012;18(6):891–7.

    Article  CAS  Google Scholar 

  18. Glück T, Silver J, Epstein M, Cao P, Farber B, Goyert SM. Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis. Eur J Med Res. 2001;6(8):351–8.

    PubMed  Google Scholar 

  19. Al-Shaiba R, McMillan DC, Angerson WJ, Leen E, McArdle CS, Horgan P. The relationship between hypoalbuminaemia, tumour volüme and tje systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer. 2004;91(2):205–7.

    Article  CAS  Google Scholar 

  20. Argiles JM, Busquets S, Lopez-Soriano FJ. Cytokines in the pathogenesis of cancer cachexia. Curr Opin Clin Nutr Metab Care. 2003;6(4):401–6.

    PubMed  CAS  Google Scholar 

  21. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer. 2004;90(9):1704–6.

    Article  CAS  Google Scholar 

  22. Kinoshita A, Onoda H, Imai N, et al. The C‑reactive protein/albümin ratio, a novel inflammation-based prognostic score predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22(3):803–10.

    Article  Google Scholar 

  23. Liu X, Sun X, Liu J, et al. Preoperative C‑reactive protein/albümin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015;8(4):339–45.

    Article  Google Scholar 

  24. Xu XL, Yu HQ, Hu W, Song Q, Mao WM. A novel inflammation-based prognostic score, the C‑reactive protein/albumin ratio predict the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS ONE. 2015;10(9):e138657.

    Article  CAS  Google Scholar 

  25. Wei XL, Wang FH, Zhang DS, et al. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C‑reactive protein/albumin ratio. BMC Cancer. 2015;15:350.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

    Mustafa Kaplan MD, Basak Cakir Guney MD, Yesim Onal Tastan MD & Hatice Selcen Bicer MD

  2. Department of Gastroenterology, Hitit University Erol Olcok Training and Research Hospital, Corum, Turkey

    Tolga Duzenli MD

  3. Department of Gastroenterology, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

    Alpaslan Tanoglu MD

Authors
  1. Mustafa Kaplan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tolga Duzenli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alpaslan Tanoglu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Basak Cakir Guney MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yesim Onal Tastan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hatice Selcen Bicer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tolga Duzenli MD.

Ethics declarations

Conflict of interest

M. Kaplan, T. Duzenli, A. Tanoglu, B.C. Guney, Y.O. Tastan, and H.S. Bicer declare that they have no competing interests.

Ethical standards

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaplan, M., Duzenli, T., Tanoglu, A. et al. Presepsin:albumin ratio and C-reactive protein:albumin ratio as novel sepsis-based prognostic scores. Wien Klin Wochenschr 132, 182–187 (2020). https://doi.org/10.1007/s00508-020-01618-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-020-01618-9

Keywords

Search

Navigation